Sistemic, Roslin Cells Partner to Establish Stem Cell Manufacturing Standards | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sistemic and Roslin Cells today announced a memorandum of understanding to promote technologies to standardize the manufacture of stem cells for use in cell therapy and drug development screening.

Financial and other terms of the MOU were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.